Membership Level
Company Headquarters
300 The American Road
Morris Plains, NJ 07950
Contact Name
Debbie Getelman
Director, National Accounts
[email protected]

About Us

Immunomedics is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping transform the lives of people with hard-to-treat cancers. Our proprietary ADC binds to Trop-2-expressing cancer cells and is internalized with the subsequent release of SN-38 via hydrolysis of the linker. SN-38 interacts with topoisomerase I and prevents re-ligation of topoisomerase I-induced single strand breaks. For additional information, please visit our website,

Access Services

TRODELVY ACCESS SERVICES is a patient access and reimbursement support program. It will help you understand specific coverage and reimbursement guidelines for TRODELVY® (sacituzumab govitecan-hziy)  180mg single-dose vial.  For full Prescribing Information, including boxed Warning, please visit

Visit Access Services


© 2020 FLASCO | Premium Website Design by The HDG